Cavanagh Bethany J

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-04-06	2026-04-01	Beam Therapeutics Inc (BEAM)	PlS Planned sale	51,681 -14.4% 296.46 US$136,195	51,681 -14.4%	296.46	US$136,195
2026-01-26	2026-01-22	Beam Therapeutics Inc (BEAM)	PlS Planned sale	97,249 +35.0% 332.75 US$2,385,152	97,249 +35.0%	332.75	US$2,385,152
2026-01-21	2026-01-20	Beam Therapeutics Inc (BEAM)	PlS Planned sale	23,275 +6.7% 264.01 US$2,158,342	23,275 +6.7%	264.01	US$2,158,342
2025-10-03	2025-10-01	Beam Therapeutics Inc (BEAM)	PlS Planned sale	467 -1.0% 24.53 US$11,456	467 -1.0%	24.53	US$11,456
2025-04-03	2025-04-01	Beam Therapeutics Inc (BEAM)	PlS Planned sale	3,015 -6.3% 18.35 US$55,330	3,015 -6.3%	18.35	US$55,330
2025-02-20	2025-02-18	Beam Therapeutics Inc (BEAM)	PlS Planned sale	6,287 -14.3% 35.00 US$220,045	6,287 -14.3%	35.00	US$220,045
2025-01-06	2025-01-02	Beam Therapeutics Inc (BEAM)	PlS Planned sale	1,117 -2.5% 24.68 US$27,568	1,117 -2.5%	24.68	US$27,568
2024-12-30	2024-12-31	Beam Therapeutics Inc (BEAM)	PrS Proposed sale	9,500 25.27 US$240,065	9,500	25.27	US$240,065
2024-10-02	2024-10-01	Beam Therapeutics Inc (BEAM)	PlS Planned sale	289 -0.6% 23.48 US$6,785	289 -0.6%	23.48	US$6,785